Enhanced Na(+) channel intermediate inactivation in Brugada syndrome.

D. W. Wang*, N. Makita, A. Kitabatake, J. R. Balser, A. L. George

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

148 Scopus citations


Brugada syndrome is an inherited cardiac disease that causes sudden death related to idiopathic ventricular fibrillation in a structurally normal heart. The disease is characterized by ST-segment elevation in the right precordial ECG leads and is frequently accompanied by an apparent right bundle-branch block. The biophysical properties of the SCN5A mutation T1620M associated with Brugada syndrome were examined for defects in intermediate inactivation (I:(M)), a gating process in Na(+) channels with kinetic features intermediate between fast and slow inactivation. Cultured mammalian cells expressing T1620M Na(+) channels in the presence of the human beta(1) subunit exhibit enhanced intermediate inactivation at both 22 degrees C and 32 degrees C compared with wild-type recombinant human heart Na(+) channels (WT-hH1). Our findings support the hypothesis that Brugada syndrome is caused, in part, by functionally reduced Na(+) current in the myocardium due to an increased proportion of Na(+) channels that enter the I:(M) state. This phenomenon may contribute significantly to arrhythmogenesis in patients with Brugada syndrome. The full text of this article is available at http://www.circresaha.org.

Original languageEnglish (US)
Pages (from-to)E37-43
JournalCirculation research
Issue number8
StatePublished - Oct 13 2000

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology


Dive into the research topics of 'Enhanced Na(+) channel intermediate inactivation in Brugada syndrome.'. Together they form a unique fingerprint.

Cite this